Real-time enrollment status for this acute kidney injury clinical trial
Current Status
Completed
Checked: June 2, 2026 at 12:27 AM UTC
| NCT Number | NCT05996835 |
| Recruiting Status | Completed |
| Condition | Acute Kidney Injury |
| Phase | Clinical Trial |
| Target Enrollment | 320 participants |
| Active Locations | 23 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | June 1, 2026 (Yesterday) |
As of June 2, 2026: Clinical trial NCT05996835 is currently completed participants. This clinical trial study for acute kidney injury is not currently accepting new participants at 23 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05996835 is currently completed. The study may resume recruiting in the future.
This trial is recruiting at 23 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05996835 was last updated Yesterday (June 1, 2026). HelloStudys verifies this status automatically.